Kura Oncology (KURA) Tops Q2 EPS by 1c

Kura Oncology (NASDAQ: KURA) reported Q2 EPS of ($0.53), $0.01 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Arena Group to rename as Paradium.AI, ticker changing to PAAI